首页|期刊导航|中国医学装备|多模态磁共振成像在不同分子亚型乳腺癌新辅助化疗早期疗效评估的价值研究

多模态磁共振成像在不同分子亚型乳腺癌新辅助化疗早期疗效评估的价值研究OA

Value of multimodal MRI in assessing early curative effect of NAC for different molecular subtypes of breast cancer

中文摘要英文摘要

目的:分析动态增强磁共振成像(DCE-MRI)和弥散加权成像(DWI)在不同乳腺癌分子亚型中新辅助化疗(NAC)早期疗效评估的价值.方法:回顾性选取2019年1月至2024年10月在常州市武进中医医院经病理诊断确诊的90例局部进展期乳腺癌并行NAC的患者临床资料,包括乳腺癌分子亚型的管腔型(Luminal A型)26例,Luminal B型41例,人类表皮生长因子(HER-2)过表达型23例.测量并记录病灶的最大直径(D)、早期强化率(EER)、最大强化率(MER)、表观弥散系数(ADC)值、相对ADC(rADC)值,并分别计算其在NAC治疗前后变化率(∆D%、∆EER%、∆MER%、∆ADC%、∆rADC%).对比乳腺癌不同分子亚型NAC临床反应程度(NAC临床显著反应和非临床显著反应);对比分析乳腺癌不同分子亚型D0、D2、△D、EER0、EER2、△EER、MER0、MER2、△MER、ADC0、ADC2、△ADC、rADC0、rADC2、△rADC指标的差异,并绘制受试者工作特征(ROC)曲线,计算ROC曲线下面积(AUC),分析DCE-MRI及DWI指标的诊断能效.结果:90例乳腺癌NAC患者NAC临床显著反应36例,非临床显著反应54例.多因素分析显示,EER0、△EER、△MER为Lumina A型乳腺癌NAC的影响因素(OR=1.370、1.607、1.182,P<0.05);△D、EER0、△EER、△MER、ADC2、rADC0为Lumina B型乳腺癌NAC的影响因素(OR=2.098、1.415、1.562、1.182、1.624、1.592,P<0.01);△D、△EER、△MER、△ADC、ADC2为HER-2过表达型乳腺癌NAC的影响因素(OR=1.705、1.522、2.142、2.185、1.537、1.592,P<0.05).结论:多模态MRI可作为评估NAC疗效的有效手段,其各个参数对不同亚型诊断能效不同.

Objective:To analyze values of dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)and diffusion-weighted imaging(DWI)in assessing early curative effect of neoadjuvant chemotherapy(NAC)for different molecular subtypes of breast cancer.Methods:A total of 90 patients with locally advanced breast cancer and NAC who underwent pathological diagnosis and were confirmed at Wujin Hospital of Traditional Chinese Medicine of Changzhou during January 2019 and October 2024 were retrospectively analyzed,which included 26 cases of Luminal A type,41 cases of Luminal B type,and 23 cases of overexpression type of Human epidermal growth factor(HER-2)in molecular subtypes of breast cancer.The maximum diameter(D),early enhancement rate(EER),maximum enhancement rate(MER),apparent diffusion coefficient(ADC)value,and relative ADC(rADC)value of the lesion were measured and recorded.The change rates of them(∆D%,∆EER%,∆MER%,∆ADC%,∆rADC%)between before and after NAC treatment were calculated respectively.The degrees of clinical reactions(Clinically significant reaction and non-clinically significant reaction about NAC)of NAC in different molecular subtypes of breast cancer were compared.The differences of D0,D2,∆ D,EER0,EER2,∆EER,MER0,MER2,∆MER,ADC0,ADC2,∆ADC,rADC0,rADC2,and ∆rADC among different molecular subtypes of breast cancer were compared and analyzed.The receiver operating characteristic(ROC)curve was drawn,and the area under curve(AUC)of the ROC curve was calculated,then,the diagnostic efficacies of DCE-MRI and DWI indicators were analyzed.Results:Among 90 patients with breast cancer who underwent NAC,36 cases occurred significantly clinical reaction and 54 cases occurred non-significantly clinical reaction.Multivariate analysis showed that EER0,∆EER,and ∆MER were influencing factors to NAC in treating Lumina A-type breast cancer(OR=1.370,1.607,1.182,P<0.05).The ∆D,EER0,∆EER,∆MER,ADC2,and rADC0 were the influencing factors to NAC in treating Lumina B-type breast cancer(OR=2.098,1.415,1.562,1.182,1.624,1.592,P<0.01).The ∆D,∆EER,∆MER,∆ADC,and ADC2 were the influencing factors to NAC in treating HER-2 overexpression-type breast cancer(OR=1.705,1.522,2.142,2.185,1.537,1.592,P<0.05).Conclusion:Multi-modal magnetic resonance can be used as an effective mean to assess the curative effect of NAC,and the diagnostic efficacies of different parameters of that for different subtypes are different.

周雪芳;贺建红;许绍奇;姜玉丹

常州市武进中医医院乳腺外科 常州 210000常州市武进中医医院乳腺外科 常州 210000常州市武进中医医院医学影像科 常州 210000常州市武进中医医院医学影像科 常州 210000

医药卫生

动态增强磁共振成像(DCE-MRI)弥散加权成像(DWI)乳腺癌分子亚型新辅助化疗(NAC)

Dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)Diffusion-weighted imaging(DWI)Breast cancerMolecular subtypesNeoadjuvant chemotherapy(NAC)

《中国医学装备》 2026 (6)

65-71,7

江苏省中医药科技发展计划(QN202317)Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan(QN202317)

10.3969/j.issn.1672-8270.2026.06.013

评论